Cullin5 drives experimental asthma exacerbations by modulating alveolar macrophage antiviral immunity

Nat Commun. 2024 Jan 4;15(1):252. doi: 10.1038/s41467-023-44168-0.

Abstract

Asthma exacerbations caused by respiratory viral infections are a serious global health problem. Impaired antiviral immunity is thought to contribute to the pathogenesis, but the underlying mechanisms remain understudied. Here using mouse models we find that Cullin5 (CUL5), a key component of Cullin-RING E3 ubiquitin ligase 5, is upregulated and associated with increased neutrophil count and influenza-induced exacerbations of house dust mite-induced asthma. By contrast, CUL5 deficiency mitigates neutrophilic lung inflammation and asthma exacerbations by augmenting IFN-β production. Mechanistically, following thymic stromal lymphopoietin stimulation, CUL5 interacts with O-GlcNAc transferase (OGT) and induces Lys48-linked polyubiquitination of OGT, blocking the effect of OGT on mitochondrial antiviral-signaling protein O-GlcNAcylation and RIG-I signaling activation. Our results thus suggest that, in mouse models, pre-existing allergic injury induces CUL5 expression, impairing antiviral immunity and promoting neutrophilic inflammation for asthma exacerbations. Targeting of the CUL5/IFN-β signaling axis may thereby serve as a possible therapy for treating asthma exacerbations.

MeSH terms

  • Animals
  • Asthma* / genetics
  • Cullin Proteins* / genetics
  • Cytokines
  • Disease Models, Animal
  • Hypersensitivity*
  • Macrophages, Alveolar
  • Mice
  • Pneumonia*

Substances

  • Cytokines
  • cullin5 protein, mouse
  • Cullin Proteins